PAOG Expects To Add CBD Nutraceuticals Revenue This Year
News provided by
Share this article
Share this article
SANDUSKY, Ohio, Feb. 18, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today highlighted the company's anticipated revenue expected this year from its CBD nutraceutical expansion. Earlier this week, the company published an online, multimedia presentation detailing the company's CBD nutraceutical development expansion plans. The presentation includes details on PAOG's strategic engagements with Puration, Inc. (USOTC: PURA), North American Cannabis Holdings, Inc. (USOTC: USMJ) and Alkme Holdings, Inc. (USOTC: ALKM).
Follow the links below to view the presentation as a Flipbook:
Learn more about PAOG at www.paogroupinc.com.